EPKINLY
Google image searchProduct monograph
Active ingredient
epcoritamab, 5 MG/ML
DIN: 02542293
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription / Schedule D
Company: ABBVIE CORPORATION
Date: 18-DEC-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
- L01FX27 — EPCORITAMAB (ATC/DDD)
